Immunoglobulins directed against NOGO

Details for Australian Patent Application No. 2006325228 (hide)

Owner Glaxo Group Limited

Inventors Kopsidas, George; Hamblin, Paul Andrew; Germaschewski, Volker; Ellis, Jonathan Henry; McAdam, Ruth; Clegg, Stephanie Jane; Prinjha, Rabinder Kumar

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2006325228

PCT Pub. Number WO2007/068750

Priority 0525662.3 16.12.05 GB

Filing date 14 December 2006

Wipo publication date 21 June 2007

Acceptance publication date 15 December 2011

International Classifications

C07K 16/22 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

Event Publications

3 July 2008 PCT application entered the National Phase

  PCT publication WO2007/068750 Priority application(s): WO2007/068750

15 December 2011 Application Accepted

  Published as AU-B-2006325228

12 April 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006325232-Dibenzene derivatives as calcium channel blockers

2006325225-Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity